1.In vitro induction,proliferation and function characterization of dendritic cells from rat bone lnRITOW cells
Nan WANG ; Qingjiu MA ; Jianguo LU ; Xianli HE ; Na LI ; Rui DONG ; Jikai YIN
Journal of Chinese Physician 2008;10(9):1176-1179
Objective To establish a method of inducing dendritic cells(DC)from rat bone marrow cells in vitro,and identify the phenotype and function characteristics.Methods The rat bone malToW cells were collected and cultured in vitro under the condition of recombinant rat GM-CSF(rrGM-CSF)and recombinant rat IL-4(rrIL-4).After 2 weeks,the morphological character of DCs was observed under light microscope and scanning electron microscope.Expression of MHC-Ⅱ,CD80 and CD86 were detected by flow cytometry.The ability to stimulate allogenic T cells of the cultured DCs was detected by mixed lymphocyte reaction.Results DCs showed typical morphology with elongated dendritic processes under inversion microscope and scanning electron microscope.DCs at day 6 revealed immature phenotype,including MHC-Ⅱ(29.03 ±4.39)%,CD80(21.98±7.08)%and CD86(25.94±6.80)%.DCs at day 12 showed higher expression of MHC-Ⅱ(74.05±5.97)%,CD80(79.85±6.53)%and CD86(81.00±7.47)%,and stimulatory capacity of allogenic T cells,compared with that in DCs at day 6.Conclusion Matured DCs could be generated from rat bone marrow cells and attendance with rrGM-CSF and rrIL-4,which present the feasibility for further research on its application to allograft immunorejection.
2.Effects of matrine on structure and function of K562 cells
Yan ZHANG ; Xiaoshan LIU ; Yujuan HE ; Lingdi MA ; Xiangru XU ; Jikai JIANG
Chinese Journal of Tissue Engineering Research 2003;7(20):2788-2789
Aim To investigate the effect of matrine on cytoskeletonof K562 cells. Methods Micropipette aspiration technique was adoptedto investigate the viscoelasticity of K562 cells, while the different ex-pression of cytoskeletal protein gene was analyzed by DNA microar-ray. Results In matrine-treated K562 cells, the viscoelastic propertiesKI, K2 and were decreased significantly from 726 ± 215 to 432 ±67,433 ±119 to 242±31, 72±38 to 50±15 respectively, and the geneexpression of prefoldin and ezrin was much stronger than that of controlcells. Conclusion The strueture and function can be changed in ma-trine-treated K562 cells.
3.Clinical effect of laparoscopic splenectomy combined with pericardial devascularization for the treatment of 310 patients with portal hypertension
Xiaojun WU ; Yan XU ; Jiangbin LI ; Jiaxing HE ; Jikai YIN ; Jianguo LU ; Rui DONG
Chinese Journal of Digestive Surgery 2017;16(11):1128-1131
Objective To investigate the clinical effect of laparoscopic splenectomy combined with pericardial devascularization for the treatment of portal hypertension.Methods The retrospective cross-sectional study was conducted.The clinical data of 310 patients with portal hypertension who underwent laparoscopic splenectomy combined with pericardial devascularization in the Tangdu Hospital of Fourth Military Medical University between January 2012 and June 2016 were collected.All the patients underwent laparoscopic splenectomy combined with pericardial devascularization.Observation indicators:(1) surgical and postoperative situations;(2) follow-up situations.Follow-up using outpatient examination and telephone interview was performed to detect the gastrointestinal rebleeding and postoperative survival of patients up to January 2017.Measurement data with normal distribution and skewed distribution were respectively represented as average number (range) and M (range).Results (1) Surgical and postoperative situations:all patients underwent successful operation.Twelve patients converted to open surgery due to intractable bleeding and 298 underwent totally laparoscopic splenectomy combined with pericardial devascularization.Average operation time,average volume of intraoperative blood loss,average time of gastrointestinal function recovery and average time of postoperative abdominal drainage-tube removal of 310 patients were 192.5 minutes (range,120.0-300.0 minutes),402.3 mL (range,150.0-1 200.0 mL),2.4 days (range,1.0-4.0 days) and 4.2 days (range,2.0-8.0 days),respectively.Among 11 of 310 patients with postoperative complications,1 died of acute severe hemorrhage of upper digestive tract,5 with intra-abdominal bleeding received successful hemostasis (3 undergoing reoperation and 2 undergoing conservative treatment),2 with pleural effusion were improved by thoracentesis and drainage,2 with pancreatic leakage and 1 with pulmonary infection were cured by conservative treatment.Other 299 patients didn't have postoperative complications.Duration of postoperative hospital stay of 310 patients was 6.4 days (range,5.0-9.0 days).(2) Follow-up situations:260 of 309 patients were followed up for 6-60 months,with a median time of 26 months.During the follow-up,1 patient died of acute portal vein thrombosis at 1 month postoperatively;15 with gastrointestinal rebleeding and melena were cured by conservative treatment;other patients had survival.Conclusion Laparoscopic splenectomy combined with pericardial devascularization for the treatment of portal hypertension is safe and effective.
4. Comparison of efficacy and safety of laparoscopic surgery for gallstones and common bile duct stones
Jikai HE ; Jinliang DONG ; Weizhong ZHANG ; Yeying CHU ; Shengzhen PENG ; Jinrong LIANG
Chinese Journal of Primary Medicine and Pharmacy 2019;26(11):1301-1304
Objective:
To evaluate the efficacy and safety of laparoscopic surgery in the treatment of gallstones and common bile duct stones.
Methods:
Eighty-seven patients with gallstones complicated with common bile duct stones who underwent concurrent laparoscopic surgery at Zhoushan Hospital from December 2015 to December 2017 were enrolled.The patients were divided into A group and B group according to the digital table.A group(38 cases) underwent laparoscopic cholecystectomy (LC) combined with laparoscopic common bile duct exploration (LCBDE), and B group(49 cases) underwent endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic sphincterotomy (EST) combined with laparoscopic cholecystectomy (LC). The curative effect of the two groups was observed.The operation time, the success rate of the operation and the rate of laparotomy were recorded in the two groups.The corresponding hospitalization time and cost were compared.The safety of the two different procedures was compared after surgery, and the complications of the two groups were recorded.
Results:
In A group, the average diameter of common bile duct stones was (1.02±0.25)cm, the average diameter of common bile duct diameter was (1.15±0.25)cm.In B group, the mean diameter of common bile duct stones was (0.99±0.26)cm, and the average diameter of common bile duct was (1.13±0.26) cm.The differences between the two groups were not statistically significant (
5.Associating liver partition and portal vein ligation for staged hepatectomy for the treatment ;of hepatocellular carcinoma
Xilin DU ; Kai TAN ; Jikai YIN ; Xiaojun HE ; Tao YANG ; Li ZANG ; Jianguo LU
Chinese Journal of Hepatic Surgery(Electronic Edition) 2016;5(2):91-94
Objective To discuss the experience of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for the treatment of hepatocellular carcinoma (HCC). Methods Clinical data of one patient with HCC undergoing ALPPS in Tangdu Hospital of the Forth Military Medical University in March 2015 were retrospectively analyzed. The patient was male, aged 31 years, was hospitalized at 2 weeks after interventional therapy of HCC. Hehadahistory of hepatitis B forover 20 years. No yellow skin or sclera was observed. Percussion pain of hepatic region was positive. HBsAg was positive and the level of AFP was 10 196μg/L. A massive HCC in the right lobe was observed by computer tomography (CT) scan, approximately 15 cm in diameter. The admitting diagnosis was HCC of the right lobe. Preoperative evaluation: Child-Pugh classification A. The liver volume was 3 464 ml, the right lobe was 2 693 ml and the left lobe was 771 ml assessed by CT scan. After resection of the right lobe and partial inferior left lobe, the remnant liver volume accounted for 35%of the standard liver volume (SLV). The standard remnant liver volume (SRLV) was 328 ml/m2. The patient was unable to tolerate one-stage operation and ALPPS was performed subsequently. The informed consents of the patient was obtained and the local ethical committee approval was received. Results During the ifrst-stage ALPPS, liver separation, removal of portal vein tumor thrombosis, ligation of the right branch of portal vein, partial resection of the inferior left lobe were performed. During the second-stage surgery, right hemihepatectomy was performed and chemotherapy pump was implanted in portal vein. CT scan revealed that the SRLV was 610 ml/m2, and the volume of left liver lobe grew to 1 245 ml, accounting for 86%of SLV 2 weeks after the ifrst-stage of ALPPS. The patient developed massive abdominal hemorrhage following the second-stage surgery and bleeding was stopped after receiving digital subtraction angiography (DSA) of the hepatic artery+embolization. The patient was discharged in stable condition on April 17th, 2015. Conclusions ALPPS is suitable for patients with middle- and advanced-stage HCC who are intolerable of one-stage hepatectomy. For those requiring comprehensive therapy, ALPPS can prolong the survival time of patients to provide the opportunity of receiving subsequent comprehensive treatments.
6.Targeting the chromatin structural changes of antitumor immunity
Li NIAN-NIAN ; Lun DENG-XING ; Gong NINGNING ; Meng GANG ; Du XIN-YING ; Wang HE ; Bao XIANGXIANG ; Li XIN-YANG ; Song JI-WU ; Hu KEWEI ; Li LALA ; Li SI-YING ; Liu WENBO ; Zhu WANPING ; Zhang YUNLONG ; Li JIKAI ; Yao TING ; Mou LEMING ; Han XIAOQING ; Hao FURONG ; Hu YONGCHENG ; Liu LIN ; Zhu HONGGUANG ; Wu YUYUN ; Liu BIN
Journal of Pharmaceutical Analysis 2024;14(4):460-482
Epigenomic imbalance drives abnormal transcriptional processes,promoting the onset and progression of cancer.Although defective gene regulation generally affects carcinogenesis and tumor suppression networks,tumor immunogenicity and immune cells involved in antitumor responses may also be affected by epigenomic changes,which may have significant implications for the development and application of epigenetic therapy,cancer immunotherapy,and their combinations.Herein,we focus on the impact of epigenetic regulation on tumor immune cell function and the role of key abnormal epigenetic processes,DNA methylation,histone post-translational modification,and chromatin structure in tumor immunogenicity,and introduce these epigenetic research methods.We emphasize the value of small-molecule inhibitors of epigenetic modulators in enhancing antitumor immune responses and discuss the challenges of developing treatment plans that combine epigenetic therapy and immuno-therapy through the complex interaction between cancer epigenetics and cancer immunology.